PARI eFlow®rapid Nebuliser Handset 678G8222

PARI eFlow®rapid nebuliser handset

eFlow® Technology nebuliser handset

The PARI eFlow®rapid nebuliser handset is intended to be used in combination with an eBase® Controller (type 678). Nebuliser solutions or suspensions, which are approved for the treatment of diseases of the lower airways can be administered as an aerosol for inhalation.

eFlow® Technology nebuliser handsets are used for the treatment of diseases of the lower airways. They are based on eFlow® Technology with the core component consisting of the aerosol head with the vibrating membrane. The nebuliser handsets are characterised by high efficiency and short nebulisation times (depending on the properties of the drug to be nebulised) as well as high, respirable quality of the aerosols produced.

As well as the versatile and freely available eFlow®rapid nebuliser handset, there are medication-specific nebuliser handsets designed specifically to meet the requirements of certain drug formulations and patient groups. These are only designed to nebulise one specific medication approved for use with the nebuliser handset. They are marketed with the specific medication of the pharmaceutical company in licence and are prescribed with the medication.

At a glance:

• For the treatment of the lower respiratory tract
• Efficient, fast and effective inhalation thanks to eFlow® Technology
• All nebuliser handsets can be operated with the eBase® Controller

Users worldwide benefit from the clinically tested eFlow® Technology

The eFlow®rapid nebuliser system has two main components: the eBase® Controller for power supply and device control and the eFlow®rapid nebuliser handset.

The heart of the nebuliser handset is the aerosol head with the vibrating membrane.
It produces the respirable aerosols required for therapy which are quickly transported deep into the lungs.